548 Avsnitt

  1. Accelerating the Development of Genetic Medicines with AI

    Publicerades: 2023-12-07
  2. Leveraging AI to Address the Neuropsychiatric Conditions Associated with a Rare Disease

    Publicerades: 2023-11-30
  3. In Pursuit of a Treatment for His Son, A Lawyer Becomes a Biotech Executive

    Publicerades: 2023-11-22
  4. In Push for Treatment, a Patient Organization Becomes a Trial Sponsor

    Publicerades: 2023-11-16
  5. Delayed Diagnosis of Rare Diseases Takes Staggering Economic Toll

    Publicerades: 2023-11-09
  6. A Cell Therapy to Control Heart-Damaging Inflammation in Duchenne

    Publicerades: 2023-11-02
  7. Stimulating the Growth of Muscle Mass in People with Neuromuscular Diseases

    Publicerades: 2023-10-26
  8. Turning Grief into Action

    Publicerades: 2023-10-19
  9. A Plea to the FDA to Give an Ultra-Rare Disease Drug a Fair Hearing

    Publicerades: 2023-10-12
  10. How the Woolly Mammoth Beat a Path to Better Gene Therapies

    Publicerades: 2023-10-05
  11. A Genetic Counselor’s Journey into Patient Advocacy

    Publicerades: 2023-09-28
  12. A Company in the Fold of Rare Disease

    Publicerades: 2023-09-21
  13. Disabling Antibodies that Drive Rare, Immunological Conditions

    Publicerades: 2023-09-14
  14. Keeping the Sentinels of the Brain Vigilant

    Publicerades: 2023-09-07
  15. Considering the Unfinished Work in Cystic Fibrosis

    Publicerades: 2023-08-31
  16. How to Advocate for Yourself as You Battle Cancer

    Publicerades: 2023-08-24
  17. Targeting Neuroinflammation to Treat ALS

    Publicerades: 2023-08-17
  18. Leveraging Community Partnerships to Address a Rare Disease Behind a Medical Mystery in New Mexico

    Publicerades: 2023-08-10
  19. Accelerating Gene Editing Therapies for Rare, Neurological Conditions

    Publicerades: 2023-08-03
  20. Inhibiting Electrical Activity in Rare, Seizure Disorders

    Publicerades: 2023-07-27

5 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site